Based on our experimental results involving BC cell lines and patient specimens, we found an increased PAF-AH expression in BRCA1 mutant BC cells and identify PAF-AH as a potential negative regulator of the canonical Wnt/β-catenin pathway. This evidence concerns the gene BRCA1 and breast cancer.